Browse > Article
http://dx.doi.org/10.7314/APJCP.2013.14.10.5761

The XRCC1 Arg399Gln Genetic Polymorphism Contributes to Hepatocellular Carcinoma Susceptibility: An Updated Meta-analysis  

Pan, Yan (Department of Integrative Oncology, Fudan University Shanghai Cancer Center)
Zhao, Lei (School of Chinese Medicine, Research Center of Heart, Brain, Hormone & Healthy Aging, The University of Hong Kong)
Chen, Xing-Miao (School of Chinese Medicine, Research Center of Heart, Brain, Hormone & Healthy Aging, The University of Hong Kong)
Gu, Yong (School of Chinese Medicine, Research Center of Heart, Brain, Hormone & Healthy Aging, The University of Hong Kong)
Shen, Jian-Gang (School of Chinese Medicine, Research Center of Heart, Brain, Hormone & Healthy Aging, The University of Hong Kong)
Liu, Lu-Ming (Department of Integrative Oncology, Fudan University Shanghai Cancer Center)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.14, no.10, 2013 , pp. 5761-5767 More about this Journal
Abstract
The potential correlation of X-ray repair cross-complementing group 1 (XRCC1) Arg399Gln polymorphism with hepatocellular carcinoma (HCC) susceptibility is ambiguous. Taking account of inconsistent results of previous meta-analyses and new emerging literatures, we conducted a meta-analysis covering 15 case-control datasets to evaluate the relationship. Relevant studies from Medline, Embase and CNKI were retrieved. A fixed-effect model or a random-effect model, depending on between-study heterogeneity, were applied to estimate the association between XRCC1 polymorphism Arg399Gln and HCC risk with the results presented as odds ratios (ORs) and 95% confidence intervals (95% CIs). In accordance with Hardy-Weinberg equilibrium, 15 studies with data for 6,556 individuals were enrolled in this systematic review. For overall HCC,thr XRCC1 polymorphism Arg399Gln was significantly associated with HCC susceptibility in a homozygote model as well as in a dominant model (G/G vs. A/A, OR=1.253, p=0.028; G/G+A/G vs. A/A, OR= 1.281, p=0.047, respectively), but not in a heterozygote model (A/G vs. A/A, OR=1.271, p=0.066) or a recessive model (G/G vs. A/G + A/A, OR= 1.049, p=0.542). Similar results were also observed on stratification analysis by ethnicity (A/G vs. A/A, OR=1.357, p=0.025; G/G vs. A/A, OR=1.310, p=0.011; G/G+A/G vs. A/A, OR= 1.371, p=0.013). However, no potential contribution of XRCC1 Arg399Gln polymorphism to HCC susceptibility in HBV/HCV subgroups was identified. No publication bias was found in this study. In conclusion, the XRCC1 Arg399Gln polymorphism contributes to HCC susceptibility. Due to the lack of studies in Western countries, further large-sample and rigorous studies are needed to validate the findings.
Keywords
Hepatocellular carcinoma; meta-analysis; SNPs; X-ray repair cross-complementing group 1;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Price BD, D'Andrea AD (2013). Chromatin remodeling at DNA double-strand breaks. Cell, 152, 1344-54.   DOI   ScienceOn
2 Ren Y, Wang DS, Li Z (2008). Study on the relationship between gene XRCC1 codon 399 single nucleotide polymorphisms and primary hepatic carcinoma in Han nationality. Chin J Clin Hepatol, 24, 361-5. (article in Chinese)
3 Salanti G, Amountza G, Ntzani EE, loannidis JP (2005). Hardy-Weinberg equilibrium in genetic association studies: an empirical evaluation of reporting, deviations, and power. Eur J Hum Genet, 13, 840-8.   DOI   ScienceOn
4 Seeberg E, Eide L, Bjoras M (1995). The base excision repair pathway. Trends Biochem Sci, 20, 391-7.   DOI   ScienceOn
5 Siegel R, Naishadham D, Jemal A (2012). Cancer statistics, 2012. CA Cancer J Clin, 62, 10-29.   DOI   ScienceOn
6 Stern MC, Umbach DM, Lunn RM, Taylor JA (2002). DNA repair gene XRCC3 codon 241 polymorphism, its interaction with smoking and XRCC1 polymorphisms, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev, 11, 939-43.
7 Vidal AE, Boiteux S, Hickson ID, Radicella JP (2001). XRCC1 coordinates the initial and late stages of DNA abasic site repair through protein-protein interactions. EMBO J, 20, 6530-9.   DOI   ScienceOn
8 Su HY (2008). A case-control study on association between genetic polymorphisms of DNA repair and hepatic cell cancer susceptibility. Available at http://dlib.cnki.net/kns50/detail/aspx?dbname = CDFD2008&filename = 2008083042.nh (accessed 30 April 2013) (article in Chinese)
9 Tang YT, Li XP, Liu TQ, et al (2011). Genetic polymorphisms of DNA repair genes in patients with hepatocellular carcinoma. Shandong Med J, 51, 19-20. (article in Chinese)
10 Trikalinos TA, Salanti G, Khoury MJ, loannidis JP (2006). Impact of violations and deviations in Hardy-Weinberg equilibrium on postulated gene-disease associations. Am J Epidermiol, 163, 300-9.
11 Wang B, Wang D, Huang G, et al (2010). XRCC1 polymorphisms and risk of colorectal cancer: a meta-analysis. Int J Colorectal Dis, 25, 313-21   DOI   ScienceOn
12 Wang C, Sun Y, Han R (2008). XRCC1 genetic polymorphisms and bladder cancer susceptibility: a meta-analysis. Urology, 72, 869-72.   DOI   ScienceOn
13 Wang DS (2006). Serological diagnosis and DNA repair gene XRCC1 polymorphism in patients with primary liver cancer. Available at http://dlib.cnki.net/kns50/detail.aspx?dbname = CMFD2007&filename = 2007101142.nh (accessed 30 April 2013) (article in Chinese)
14 Whitehouse CJ, Taylor RM, Thistlethwaite A, et al (2001). XRCC1 stimulates human polynucleotide kinase activity at damaged DNA termini and accelerates DNA single-strand break repair. Cell, 104, 107-17.   DOI   ScienceOn
15 Yang JL, Han YN, Zhen SG (2004). Influence of human XRCC1-399 single nucleotide polymorphism on primary hepatocytic carcinoma. Tumor, 24, 322-4. (article in Chinese)
16 Wu H (2009). Correlation between DNA Pepair Gene XRCC1 Single Nucleotide Polymorphism and Susceptibility to Hepatocellular Carcinoma in Fusui County of Guangxi. Available at http://dlib.cnki.net/kns50/detail.aspx?dbname = CMFD 2009&filename = 2009132690.nh. (accessed 30 April 2013) (article in Chinese)
17 Wu H (2009). Correlation between DNA repair gene XRCC1 single nucleotide polymorphism and susceptibility to hepatocellular carcinoma in Fusui County of Guangxi. Available at http://dlib.cnki.net/kns50/detail.aspx?dbname=CMFD2009&filename=2009132690.nh (accessed 30 April 2013) (article in Chinese)
18 Zeng XY, Huang JM, Xu JW, et al (2013). Meta-analysis demonstrates lack of a relationship between XRCC1 399 gene polymorphisms and susceptibility to hepatocellular carcinoma. Genet Mol Res, 12, 1916-23.   DOI   ScienceOn
19 Xie T, Wang ZG, Zhang JL, Liu H (2012). X-ray repair cross-complementing group 1 polymorphisms and hepatocellular carcinoma: a meta-analysis. World J Gastroenterol, 18, 4207 -14.   DOI   ScienceOn
20 Yu MW, Yang SY, Pan IJ, et al (2003). Polymorphisms in XRCC1 and glutathione S-transferase genes and hepatitis B-related hepatocellular carcinoma. J Natl Cancer Inst, 95, 1485-8.   DOI   ScienceOn
21 Zeng XY, Yu HP, Qiu XQ, et al (2010). A case-control study of polymorphism of XRCC1 gene and the risk of hepatocellular carcinoma. Chin J Dis Control Prev, 14, 760-3. (article in Chinese)
22 Zhang H, Wang P, Dai L, et al (2010). Meta-analysis of the relationship between polymorphisms of 399 point of X-ray repair cross complementing gene group 1 and hepatocellular carcinoma. Wei Sheng Yan Jiu, 39, 664-8. (article in Chinese)
23 Chen CC, Yang SY, Liu CY, et al (2005). Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma. Int J Epidemiol, 34, 1310-8.   DOI   ScienceOn
24 Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50, 1088-101.   DOI   ScienceOn
25 Borentain P, Gerolami V, Ananian P, et al (2007). DNA-repair and carcinogen- metabilising enzymes genetic polymorphisms as an independent risk factor for hepatocellular carcinoma in Caucasian liver-transplanted patients. Eur J Cancer, 43, 2479-86.   DOI   ScienceOn
26 Bose S, Tripathi DM, Sukriti, et al (2013). Genetic polymorphisms of CYP2E1 and DNA repair genes HOGG1 and XRCC1 Association with hepatitis B related advanced liver disease and cancer. Gene, 519, 231-7.   DOI   ScienceOn
27 DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88.   DOI   ScienceOn
28 Chacko P, Rajan B, Joseph T, Mathew BS, Pillai MR (2005). Polymorphisms in DNA repair gene XRCC1 and increased genetic susceptibility to breast cancer. Breast Cancer Res Treat, 89, 15-21.   DOI   ScienceOn
29 Cochran WG (1954). The combination of estimates from different experiments. Biometrics, 10, 101-29.   DOI   ScienceOn
30 Ding F, Chen YY, Xie YA (2012). Correlations between XRCC1 genetic polymorphism Arg399Gln and susceptibility to hepa-tocellular carcinoma in liver cancer family clusters in Fusui county, Guangxi. Chin J of Oncol Prev and Treat, 4, 33-7. (article in Chinese)
31 Egger M, Davey Smith G, Schneider M, Minder C (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34.   DOI   ScienceOn
32 Geng J, Zhang Q, Zhu C, Wang J, Chen L (2009). XRCC1 genetic polymorphism Arg399Gln and prostate cancer risk: a meta-analysis. Urology, 74, 648-53.   DOI   ScienceOn
33 Geng J, Zhang YW, Huang GC, Chen LB (2008). XRCC1 genetic polymorphism Arg399Gln and gastric cancer risk: a meta-analysis. World J Gastroenterol, 14, 6733-7.   DOI
34 Gulnaz A, Sayyed AH, Amin F, et al (2013). Association of XRCC1, XRCC3, and XPD genetic polymorphism with an increased risk of hepatocellular carcinoma because of the hepatitis B and C virus. Eur J Gastroenterol Hepatol, 25, 166-79.   DOI
35 Han YN, Yang JL, Zhen SG (2004). Study on the association of human XRCC1-399 single nucleotide polymorphism and primary hepatocytic carcinoma. Liver, 12, 235-7. (article in Chinese)
36 Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003). Measuring inconsistency in meta- analyses. BMJ, 327, 557-60.   DOI   ScienceOn
37 Guo LY, Jin XP, Niu W, et al (2012). Association of XPD and XRCC1 Genetic Polymorphisms with Hepatocellular Carcinoma Risk. Asian Pac J Cancer Prev, 13, 4423-6.   과학기술학회마을   DOI   ScienceOn
38 Han X, Xing Q, Li Y, et al (2012). Study on the DNA repair gene XRCC1 and XRCC3 polymorphism in prediction and prognosis of hepatocellular carcinoma risk. Hepatogastroenterology, 59, 2285-9.
39 Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K (2002). A comprehensive review of genetic association studies. Genet Med, 4, 45-61.   DOI   ScienceOn
40 Hu Z, Ma H, Chen F, Wei Q, Shen H (2005). XRCC1 polymorphisms and cancer risk: meta-analysis of 38 case-control studies. Cancer Epidemiol Biomarkers Prev, 14, 1810-8.   DOI   ScienceOn
41 Jia ZF, Su HY, Li XL, et al (2010). Polymorphisms of UGT1A7 and XRCC1 are associated with an increased risk of hepatocellular carcinoma in Northeast China. Chin J Cancer Res, 22, 260-6.   DOI   ScienceOn
42 Jung SW, Park NH, Shin JW, et al (2012). Polymorphisms of DNA repair genes in Korean hepatocellular carcinoma patients with chronic hepatitis B. J Hepatol, 57, 621-7.   DOI   ScienceOn
43 Kiran M, Chawla YK, Jain M, Kaur J (2009). Haplotypes of microsomal epoxide hydrolase and x-ray cross-complementing group 1 genes in Indian hepatocellular carcinoma patients. DNA Cell Biol, 28, 573-7.   DOI   ScienceOn
44 Li J, Li Z, Feng L, Guo W, Zhang S (2013). Polymorphisms of DNA repair gene XRCC1 and hepatocellular carcinoma risk among East Asians: a meta-analysis. Tumor Biol, 34, 261-9.   DOI   ScienceOn
45 Lahtz C, Pfeifer GP (2011). Epigenetic changes of DNA repair genes in cancer. J Mol Cell Biol, 3, 51-8.   DOI   ScienceOn
46 Kirk GD, Turner PC, Gong Y, et al (2005). Hepatocellular carcinoma and polymorphism in carcinogen-metabolizing and DNA repair enzymes in a population with aflatoxin exposure and hepatitis B virus endemicity. Cancer Epidemiol Biomarkers Prev, 14, 373-9.   DOI   ScienceOn
47 Lamerdin JE, Montgomery MA, Stilwagen SA, et al (1995). Genomic sequence comparison of human and mouse XRCC1 DNA repair gene regions. Genomics, 25, 547-54.   DOI   ScienceOn
48 Li QW, Lu CR, Ye M, Xiao WH, Liang J (2012). Evaluation of DNA repair gene XRCC1 polymorphism in prediction and prognosis of hepatocellular carcinoma risk. Asian Pac J Cancer Prev, 13, 191-4.   과학기술학회마을   DOI   ScienceOn
49 Lindahl T, Wood RD (1999). Quality control by DNA repair. Science, 286, 1897-905.   DOI   ScienceOn
50 Liu F, Li B, Wei Y, et al (2011). XRCC1 genetic polymorphism Arg399Gln and hepatocellular carcinoma risk: a meta-analysis. Liver Int, 31, 802-9.   DOI   ScienceOn
51 Long XD, Ma Y, Wei YP, Deng ZL (2006). The polymorphisms of GSTM1, GSTT1, HYL1*2, and XRCC1, and aflatoxin B1-related hepatocellular carcinoma in Guangxi population, China. Hepatol Res, 36, 48-55.   DOI   ScienceOn
52 Lopez LJ, Marrero JA (2004). Hepatocellular carcinoma. Curr Opin Gastroenterol, 20, 248-53.   DOI   ScienceOn
53 Long XD (2004). Polymorphism of DNA repair gene XRCC1 and risk of aflatoxin B1-related hepatocellular carcinoma. Available at http://dlib.cnki.net/kns50/detail.aspx?dbname = CMFD2004&filename = 200480557.nh (accessed 30 April 2013) (article in Chinese)
54 Long XD, Ma Y, Huang HD, et al (2008). Polymorphism of XRCC1 and the frequency of mutation in codon 249 of the p53 gene in hepatocellular carcinoma among guangxi population, China. Mol Carcinog, 47, 295-300.   DOI   ScienceOn
55 Long XD, Ma Y, Wei YP (2005). X-ray repair cross-complementing group1 (XRCC1) Arg399Gln polymorphism and aflatoxin B1 (AFB1)-related hepatocellular carcinoma (HCC) in Guangxi population. Chin J Cancer Res, 17, 17-21.   DOI   ScienceOn
56 Mantel N, Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48.
57 McKillop IH, Moran DM, Jin X, Koniaris LG (2006). Molecular pathogenesis of hepatocellular carcinoma. J Surg Res, 136, 125-35.   DOI   ScienceOn
58 Miller MC 3rd, Mohrenweiser HW, Bell DA (2001). Genetic variability in susceptibility and response to toxicants. Toxicol Lett, 120, 269-80.   DOI   ScienceOn
59 Saadat M, Ansari-Lari M (2009). Polymorphism of XRCC1 (at codon 399) and susceptibility to breast cancer, a meta-analysis of the literature. Breast Cancer Res Treat, 115, 137-44.   DOI   ScienceOn
60 Pan HZ, Liang J, Yu Z, et al (2011). Polymorphism of DNA repair gene XRCC1 and hepatocellular carcinoma risk in Chinese population. Asian Pac J Cancer Prev, 12, 2947-50.
61 Smith TR, Miler MS, Lohman K, et al (2003). Polymorphisms of XRCC1 and XRCC3 genes and susceptibility to breast cancer. Cancer Lett, 190, 183-90.   DOI   ScienceOn
62 Mohana Devi S, Balachandar V, Arun M, et al (2013). Analysis of genetic damage and gene polymorphism in hepatocellular carcinoma (HCC) patients in a South Indian population. Dig Dis Sci, 58, 759-67.   DOI   ScienceOn
63 Akinyinka OO, Falade AG, Ogunbiyi O, Johnson AO (2001). Hepatocellular carcinoma in Nigerian children. Ann Trop Paediatr, 21, 165-8.   DOI   ScienceOn
64 Kiran M, Saxena R, Chawla YK, Kaur J (2009). Polymorphism of DNA repair gene XRCC1 and hepatitis-related hepatocellular carcinoma risk in Indian population. Mol Cell Biochem, 327, 7-13.   DOI   ScienceOn
65 Kiyohara C, Takayama K, Nakanishi Y (2006). Association of genetic polymorphisms in the base excision repair pathway with lung cancer risk: a meta-analysis. Lung Cancer, 54, 267-83.   DOI   ScienceOn